Effectiveness and safety of trifluridine/tipiracil in patients with metastatic colorectal cancer in clinical practice in Poland

被引：0
|
作者：
Radecka, B. [1 ]
Gelej, M. [2 ]
Streb, J. [3 ]
Siedlaczek, A. [4 ]
Kryka, K. [3 ]
Tokajuk, P. [5 ]
Winsko-Szczesnowicz, K. [5 ]
Czernek, U. [6 ]
Sobczak, M. [7 ]
Malik, M. [8 ]
Bodnar, L. [9 ]
Foszczynska-Kloda, M. [10 ]
Hetman, K. [10 ]
Skiewicz, M. Welnicka-Ja [11 ]
Wierzbicka, K. [11 ]
Orlikowska, M. [12 ]
Becht, R. [13 ]
Deptala, A. [14 ]
Itrych, B. [15 ]
Kania-Zembaczynska, B. [16 ]
机构：
[1] Univ Opole, Inst Med Sci, Dept Oncol, Opole, Poland
[2] Tadeusz Koszarowski Reg Canc Ctr, Dept Clin Oncol, Opole, Poland
[3] Jagiellonian Univ Hosp Krakow, Krakow, Poland
[4] Univ Opole, Inst Math & Comp Sci, Opole, Poland
[5] Comprehens Canc Ctr Bialystok, Med Oncol Dept, Bialystok, Poland
[6] Med Univ Lodz, Copernicus Mem Hosp Lodz, Dept Chemotherapy, Lodz, Poland
[7] Copernicus Mem Hosp Lodz, Lodz, Poland
[8] Lower Silesian Oncol Ctr, Clin Oncol Dept, Wroclaw, Poland
[9] Warmia & Mazury Oncol Ctr, MSWiA Hosp, Oncol & Immunooncol Clin, Olsztyn, Poland
[10] West Pomeranian Oncol Ctr Szczecin, Szczecin, Poland
[11] Med Univ Gdansk, Dept Oncol & Radiotherapy, Gdansk, Poland
[12] Kociewie Hlth Ctr Starogard Gdanski, Oncol Dept, Starogard Gdanski, Poland
[13] Pomeranian Med Univ, Clin Dept Oncol Chemotherapy & Canc Immunotherapy, Szczecin, Poland
[14] Med Univ Warsaw, Cent Clin Hosp MSWiA, Clin Oncol & Hematol, Warsaw, Poland
[15] Cent Clin Hosp MSWiA, Clin Oncol & Breast Dis, Ctr Postgrad Med Educ, Warsaw, Poland
[16] Beskidian Oncol Ctr Bielsko Biala, Dept Oncol & Oncohematol, Bielsko Biala, Poland
来源：
ANNALS OF ONCOLOGY | 2020年 / 31卷
关键词：
D O I：
10.1016/j.annonc.2020.04.139
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-57
引用
收藏
页码：S108 / S108
页数：1
相关论文
共 50 条
  • [21] Efficacy and safety of trifluridine/tipiracil plus bevacizumab and trifluridine/tipiracil or regorafenib monotherapy for chemorefractory metastatic colorectal cancer: a retrospective study
    Chida, Keigo
    Kotani, Daisuke
    Nakamura, Yoshiaki
    Kawazoe, Akihito
    Kuboki, Yasutoshi
    Shitara, Kohei
    Kojima, Takashi
    Taniguchi, Hiroya
    Watanabe, Jun
    Endo, Itaru
    Yoshino, Takayuki
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2021, 13
  • [22] Neutropenia in metastatic colorectal cancer receiving trifluridine/tipiracil
    Colloca, G.
    Venturino, A.
    Guarneri, D.
    ANNALS OF ONCOLOGY, 2020, 31 (07) : 958 - 958
  • [23] Factors associated with effectiveness of trifluridine/tipiracil versus regorafenib in patients with pretreated metastatic colorectal cancer (mCRC)
    Grell, Peter
    Borilova, Simona
    Schwanzerova, Renata
    Kukolikova, Sabina
    Dvorak, Josef
    Vocka, Michal
    John, Stanislav
    Buchler, Tomas
    Selingerova, Iveta
    Petruzelka, Lubos B.
    Vyzula, Rostislav
    Kiss, Igor
    Obermannova, Radka
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [24] Efficacy and safety of trifluridine/tipiracil plus bevacizumab versus trifluridine/tipiracil monotherapy for refractory metastatic colorectal cancer: a retrospective cohort study
    Li, Rong-Rong
    Zhou, Hui-Jun
    Zeng, De-Yu
    Jiang, Shao-Feng
    Liu, Wu
    Fruehling, Petter
    Liu, Zhen-Yang
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2024, 15 (02) : 612 - 629
  • [25] Trifluridine/tipiracil (FTD/TPI) and regorafenib in older patients with metastatic colorectal cancer
    Victorino, Ana Paula Ornellas S.
    Meton, Fernando
    Mardegan, Luciana
    Festa, Juliana
    Piranda, Diogo N.
    Araujo, Kelly Borges
    JOURNAL OF GERIATRIC ONCOLOGY, 2023, 14 (04)
  • [26] Prognostic factors in refractory metastatic colorectal cancer patients treated with Trifluridine/Tipiracil
    Koper, Agnieszka
    Wilenski, Slawomir
    Sledzinska, Paulina
    Bebyn, Marek
    Koper, Krzysztof
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (12) : 10867 - 10877
  • [27] Italian results of the PRECONNECT study: safety and efficacy of trifluridine/tipiracil in metastatic colorectal cancer
    Zaniboni, Alberto
    Barone, Carlo Antonio
    Banzi, Maria Chiara
    Bergamo, Francesca
    Blasi, Livio
    Bordonaro, Roberto
    Di Bartolomeo, Maria
    Di Costanzo, Francesco
    Frassineti, Giovanni Luca
    Garufi, Carlo
    Giuliani, Francesco
    Latiano, Tiziana Pia
    Martinelli, Erika
    Personeni, Nicola
    Racca, Patrizia
    Tamburini, Emiliano
    Tonini, Giuseppe
    Besse, Marie Georges
    Spione, Mario
    Falcone, Alfredo
    FUTURE ONCOLOGY, 2021, 17 (18) : 2315 - 2324
  • [28] Safety and efficacy of trifluridine/tipiracil in previously treated metastatic colorectal cancer: PRECONNECT Turkey
    Ozet, Ahmet
    Dane, Faysal
    Aykan, Nuri Faruk
    Yalcin, Suayib
    Evrensel, Turkkan
    Ozkan, Metin
    Karabulut, Bulent
    Ormeci, Merve Nur
    Atasev, Ozan
    Vidot, Loick
    Cicin, Irfan
    FUTURE ONCOLOGY, 2022, 18 (29) : 3267 - 3276
  • [29] Trifluridine/tipiracil (FTD/TPI) in metastatic colorectal cancer treatment
    Michel, Patryk S.
    Jankowski, Marek
    Sigorski, Dawid
    Kubiatowski, Tomasz
    ONCOLOGY IN CLINICAL PRACTICE, 2024,
  • [30] A Retrospective Study of Trifluridine/Tipiracil with Fruquintinib in Patients with Chemorefractory Metastatic Colorectal Cancer
    Zou, Jiayun
    Wang, Yuanyuan
    Xu, Jiayu
    Li, Jinna
    Wang, Tianzhuo
    Zhang, Ying
    Bai, Yibo
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (01)
12345